Literature DB >> 25161943

Spontaneous or secondary to intravitreal injections of anti-angiogenic agents retinal pigment epithelial tears in age-related macular degeneration.

Pia E Leon1, Sandro Saviano1, Andrea Zanei1, Marco R Pastore1, Elvira Guaglione1, Alessandro Mangogna1, Daniele Tognetto1.   

Abstract

AIM: To evaluate the visual function evolution of retinal pigment epithelial (RPE) tears in patients with age-related macular degeneration (AMD) according to type of occurrence [spontaneous or secondary to anti-vascular endothelial growth factor (anti-VEGF) injection] and the topographic location of the tear after a two-year follow-up period.
METHODS: A total of 15 eyes of 14 patients with RPE tears in exudative AMD were analyzed retrospectively at the University Eye Clinic of Trieste. Inclusion criteria were: patient age of 50 or older with AMD and RPE tears both spontaneous occurring or post anti-VEGF treatment. Screening included: careful medical history, complete ophthalmological examination, fluorescein angiography (FA), indocyanine green angiography (ICG), autofluorescence and infrared imaging and optical coherence tomography (OCT). Patients were evaluated every month for visual acuity (VA), fundus examination and OCT. Other data reported were: presence of PED, number of injections before the tear, location of the lesion.
RESULTS: Mean follow-up was 24wk (SD±4wk). A total of 15 eyes were studied for RPE tear. In 6 cases (40%), the RPE tears occurred within two years of anti-VEGF injections the others occurred spontaneously. In 13 cases (86.6%), the RPE tear was associated with pigment epithelial detachment (PED). In 7 cases (46.6%), the RPE tear occurred in the central area of the retina and involved the fovea. Two lesions were found in the parafoveal region, six in the extra-macular area. In all cases visual acuity decreased at the end of the follow-up period (P<0.01) independently of the type or the topographical location of the lesion.
CONCLUSION: RPE tear occurs in exudative AMD as a spontaneous complication or in relation to anti-VEGF injections. Visual acuity decreased significantly and gradually in the follow-up period in all cases. No correlation was found between visual loss and the type of onset or the topographic location of the tears.

Entities:  

Keywords:  age-related macular degeneration; anti-vascular endothelial growth factor treatment; retinal pigment epithelial; tears; visual acuity

Year:  2014        PMID: 25161943      PMCID: PMC4137207          DOI: 10.3980/j.issn.2222-3959.2014.04.18

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

1.  Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.

Authors:  F Gelisken; W Inhoffen; M Partsch; U Schneider; I Kreissig
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

2.  A new grading system for retinal pigment epithelial tears.

Authors:  David Sarraf; Shantan Reddy; Allen Chiang; Fei Yu; Atul Jain
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

3.  Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.

Authors:  Gary K Y Lee; Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.117

4.  Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Authors:  Ryan M Rich; Philip J Rosenfeld; Carmen A Puliafito; Sander R Dubovy; Janet L Davis; Harry W Flynn; Serafin Gonzalez; William J Feuer; Richard C Lin; Geeta A Lalwani; Jackie K Nguyen; Gaurav Kumar
Journal:  Retina       Date:  2006 May-Jun       Impact factor: 4.256

5.  Retinal pigment epithelial tear following intravitreal pegaptanib sodium.

Authors:  Mandeep Singh Dhalla; Kevin J Blinder; Asheesh Tewari; Seenu M Hariprasad; Rajendra S Apte
Journal:  Am J Ophthalmol       Date:  2006-04       Impact factor: 5.258

6.  Pathogenesis of tears of the retinal pigment epithelium.

Authors:  J D Gass
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

7.  Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.

Authors:  C H Meyer; S Mennel; J C Schmidt; P Kroll
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

8.  Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.

Authors:  Ulrich H M Spandau; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2006-12       Impact factor: 5.258

9.  Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Authors:  Ugo Introini; Ana Torres Gimeno; Fabrizio Scotti; Marco Setaccioli; Silvia Giatsidis; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

Review 10.  Tears of the retinal pigment epithelium: an old problem in a new era.

Authors:  Louis K Chang; David Sarraf
Journal:  Retina       Date:  2007-06       Impact factor: 4.256

View more
  2 in total

1.  Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab.

Authors:  Alon Tiosano; Aviel Hadad; Noam Yanculovic
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

2.  Physical disruption of cell-cell contact induces VEGF expression in RPE cells.

Authors:  Farhad Farjood; Elizabeth Vargis
Journal:  Mol Vis       Date:  2017-07-17       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.